What are the Most Promising Coronavirus Vaccines Undertrials?

0
56

Coronavirus cases in the world have crossed 3.7 million with 2.5 lack deaths globally. Scientists all over the world are racing against the time to develop a vaccine for Coronavirus. There are over 75 coronavirus vaccine candidates out of which only a few are under the trail.

China is in Phase-II of developing CanSino’s Ad5-nCoV. This vaccine contains common adenovirus, with Coronavirus-like spike protein to generate an immune response. Fever is a known side effect of the CanSiino vaccine.

U.S based biotech firm Moderna Therapeutics has developed an mRNA vaccine that contains genetic material from coronavirus to develop immunity.

Image Source: clinical trials arena

Another American company, Innovio Pharmaceuticals, has developed a DNA-based vaccine INO-4800. INO-800 can increase the production of antibodies that are known to fight Coronavirus.

Oxford university’s ChAdOx1 vaccine grabbed the headlines after the phase-I trials on humans started. If trials come out to be a success then this Oxford-developed vaccine can hit the markets as early as September.

Chinese company, Sinovac, has developed PiCoVacc. PiCoVacc vaccine contains an inactive SARS-Cov-2 to generate an immune response.

Coronavirus vaccine is estimated to be available in markets in the next 12-18 months.

LEAVE A REPLY

Please enter your comment!
Please enter your name here